Skip to main content

Table 2 Comparison of urinary parameters

From: Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial

Parameters Control Dapagliflozin 10 mg P-value
Before After Con vs Bef Bef vs Aft
24-h UUA (mmol) 3.26 ± 1.29 3.53 ± 0.61 3.79 ± 1.05 0.626 0.567
24-h UNa (mmol) 174.57 ± 46.13 126.18 ± 18.89 129.61 ± 27.34 0.025 0.057
24-h UCl (mmol) 167.71 ± 53.83 129.61 ± 27.34 177.00 ± 36.43 0.125 0.055
FEUA 0.047 ± 0.044 0.062 ± 0.009 0.093 ± 0.029 0.460 0.035
FENa 4.75 ± 4.46 5.58 ± 1.19 8.35 ± 2.63 0.672 0.022
FECl 6.63 ± 6.39 7.84 ± 2.27 11.71 ± 3.74 0.674 0.015
  1. Con, control; Bef, before; Aft, after; UUA, urinary uric acid; UNa, urinary sodium; UCl, urinary chloride; FEUA, fractional excretion of uric acid; FENa, fractional excretion of sodium; FECl, fractional excretion of chloride